Pharmacokinetics and pharmacodynamics of itepekimab in adults with moderate-to-severe atopic dermatitis: Results from two terminated phase II trials. - Kosloski MP; Guttman-Yassky E; Cork MJ; Worm M; Nahm DH; Zhu X; Ruddy MK; Harel S; Kamal MA; Goulaouic H; Xu CR; Avetisova E; et al. (Clinical and translational science, 2024)